No significant difference of pentraxin 3 levels was found between mild and severepreeclampsia.
2
Conclusions: There is a strong and specific association between various types of antiprothrombin antibodies with severepreeclampsia and spontaneous abortion.
3
It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severepreeclampsia in pregnant women.
4
Conclusions: High maternal serum levels MIF in pregnancies complicated by severepreeclampsia strongly support the role of inflammation in the pathogenesis of this disease.
5
We conclude that, with these dosages and in case of an already established disease, vitamin E does not improve fetal outcome in severepreeclampsia.
6
Methods: Checklists for management of severepreeclampsia, hypertensive emergency and eclampsia were developed in an audit cycle based on nine existing key clinical care protocols.
7
The aims of this study were to provide a comprehensive acid-base analysis in severepreeclampsia and to identify potential new biological predictors of disease severity.
8
We analyzed the urinary sediment of 30 patients with severepreeclampsia every 4 hours during early labor, delivery, and the postpartum period.
9
Antiprethrombin-1 antibody was detected in only 2 women with severepreeclampsia, whereas all 10 women with antiprethrombin antibodies were positive for antifragment-1 antibody.